1,325
Views
29
CrossRef citations to date
0
Altmetric
Research Paper

Antagonism between curcumin and the topoisomerase II inhibitor etoposide

A study of DNA damage, cell cycle regulation and death pathways

, , &
Pages 1058-1071 | Received 20 Apr 2012, Accepted 09 Jun 2012, Published online: 16 Aug 2012

References

  • Raguz S, Yagüe E. Resistance to chemotherapy: new treatments and novel insights into an old problem. Br J Cancer 2008; 99:387 - 91; http://dx.doi.org/10.1038/sj.bjc.6604510; PMID: 18665178
  • Oneschuk D, Younus J. Natural health products and cancer chemotherapy and radiation therapy. Oncol Rev 2008; 1:233 - 42; http://dx.doi.org/10.1007/s12156-008-0028-6
  • Shervington A, Pawar V, Menon S, Thakkar D, Patel R. The sensitization of glioma cells to cisplatin and tamoxifen by the use of catechin. Mol Biol Rep 2009; 36:1181 - 6; http://dx.doi.org/10.1007/s11033-008-9295-3; PMID: 18581255
  • Weissenberger J, Priester M, Bernreuther C, Rakel S, Glatzel M, Seifert V, et al. Dietary curcumin attenuates glioma growth in a syngeneic mouse model by inhibition of the JAK1,2/STAT3 signaling pathway. Clin Cancer Res 2010; 16:5781 - 95; http://dx.doi.org/10.1158/1078-0432.CCR-10-0446; PMID: 21138870
  • Syng-Ai C, Kumari AL, Khar A. Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2. Mol Cancer Ther 2004; 3:1101 - 8; PMID: 15367704
  • Hassan MI, Mabrouk GM, Shehata HH, Aboelhussein MM. Antineoplastic Effects of Bee Honey and Nigella sativa on Hepatocellular Carcinoma Cells. Integr Cancer Ther 2010; In press http://dx.doi.org/10.1177/1534735410387422; PMID: 21147814
  • Mizushima S, Nara Y, Sawamura M, Yamori Y. Effects of oral taurine supplementation on lipids and sympathetic nerve tone. Adv Exp Med Biol 1996; 403:615 - 22; PMID: 8915402
  • Hansen LT, Lundin C, Spang-Thomsen M, Petersen LN, Helleday T. The role of RAD51 in etoposide (VP16) resistance in small cell lung cancer. Int J Cancer 2003; 105:472 - 9; http://dx.doi.org/10.1002/ijc.11106; PMID: 12712436
  • Yang AK, He SM, Liu L, Liu JP, Wei MQ, Zhou SF. Herbal interactions with anticancer drugs: mechanistic and clinical considerations. Curr Med Chem 2010; 17:1635 - 78; http://dx.doi.org/10.2174/092986710791111279; PMID: 20345351
  • El-Awady RA, Ali MM, Saleh EM, Ghaleb FM. Apoptosis is the most efficient death-pathway in tumor cells after topoisomerase II inhibition. Saudi Med J 2008; 29:558 - 64; PMID: 18382799
  • Berenbaum MC. What is synergy?. Pharmacol Rev 1989; 41:93 - 141; PMID: 2692037
  • El-Awady RA, Saleh EM, Dahm-Daphi J. Targeting DNA double-strand break repair: is it the right way for sensitizing cells to 5-fluorouracil?. Anticancer Drugs 2010; 21:277 - 87; http://dx.doi.org/10.1097/CAD.0b013e328334b0ae; PMID: 20075715
  • Ying S, Myers K, Bottomley S, Helleday T, Bryant HE. BRCA2-dependent homologous recombination is required for repair of Arsenite-induced replication lesions in mammalian cells. Nucleic Acids Res 2009; 37:5105 - 13; http://dx.doi.org/10.1093/nar/gkp538; PMID: 19553191
  • El-Awady RA, Dikomey E, Dahm-Daphi J. Radiosensitivity of human tumour cells is correlated with the induction but not with the repair of DNA double-strand breaks. Br J Cancer 2003; 89:593 - 601; http://dx.doi.org/10.1038/sj.bjc.6601133; PMID: 12888835
  • Kovacs K, Lloyd R, Horvath E, Asa SL, Stefaneanu L, Killinger DW, et al. Silent somatotroph adenomas of the human pituitary. A morphologic study of three cases including immunocytochemistry, electron microscopy, in vitro examination, and in situ hybridization. Am J Pathol 1989; 134:345 - 53; PMID: 2464941
  • Zeng Z, Cortés-Ledesma F, El Khamisy SF, Caldecott KW. TDP2/TTRAP is the major 5′-tyrosyl DNA phosphodiesterase activity in vertebrate cells and is critical for cellular resistance to topoisomerase II-induced DNA damage. J Biol Chem 2011; 286:403 - 9; http://dx.doi.org/10.1074/jbc.M110.181016; PMID: 21030584
  • Sunter NJ, Cowell IG, Willmore E, Watters GP, Austin CA. Role of Topoisomerase IIβ in DNA Damage Response following IR and Etoposide. J Nucleic Acids 2010; 2010: 1-8.
  • Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998; 273:5858 - 68; http://dx.doi.org/10.1074/jbc.273.10.5858; PMID: 9488723
  • Azab SS, Salama SA, Abdel-Naim AB, Khalifa AE, El-Demerdash E, Al-Hendy A. 2-Methoxyestradiol and multidrug resistance: can 2-methoxyestradiol chemosensitize resistant breast cancer cells?. Breast Cancer Res Treat 2009; 113:9 - 19; http://dx.doi.org/10.1007/s10549-008-9898-3; PMID: 18228136
  • Nielsen D, Maare C, Skovsgaard T. Cellular resistance to anthracyclines. Gen Pharmacol 1996; 27:251 - 5; http://dx.doi.org/10.1016/0306-3623(95)02013-6; PMID: 8919638
  • Sa G, Das T. Anti cancer effects of curcumin: cycle of life and death. Cell Div 2008; 3:3 - 14; http://dx.doi.org/10.1186/1747-1028-3-14; PMID: 18211690
  • Yi T, Cho SG, Yi Z, Pang X, Rodriguez M, Wang Y, et al. Thymoquinone inhibits tumor angiogenesis and tumor growth through suppressing AKT and extracellular signal-regulated kinase signaling pathways. Mol Cancer Ther 2008; 7:1789 - 96; http://dx.doi.org/10.1158/1535-7163.MCT-08-0124; PMID: 18644991
  • Effenberger-Neidnicht K, Schobert R. Combinatorial effects of thymoquinone on the anti-cancer activity of doxorubicin. Cancer Chemother Pharmacol 2011; 67:867 - 74; http://dx.doi.org/10.1007/s00280-010-1386-x; PMID: 20582416
  • Hour TC, Chen J, Huang CY, Guan JY, Lu SH, Pu YS. Curcumin enhances cytotoxicity of chemotherapeutic agents in prostate cancer cells by inducing p21(WAF1/CIP1) and C/EBPbeta expressions and suppressing NF-kappaB activation. Prostate 2002; 51:211 - 8; http://dx.doi.org/10.1002/pros.10089; PMID: 11967955
  • Arafa SA, Zhu Q, Shah ZI, Wani G, Barakat BM, Racoma I, et al. Thymoquinone up-regulates PTEN expression and induces apoptosis in doxorubicin-resistant human breast cancer cells. Mutat Res 2011; 706:28 - 35; http://dx.doi.org/10.1016/j.mrfmmm.2010.10.007; PMID: 21040738
  • Gurung RL, Lim SN, Khaw AK, Soon JF, Shenoy K, Mohamed Ali S, et al. Thymoquinone induces telomere shortening, DNA damage and apoptosis in human glioblastoma cells. PLoS One 2010; 5:e12124; http://dx.doi.org/10.1371/journal.pone.0012124; PMID: 20711342
  • Jafri SH, Glass J, Shi R, Zhang S, Prince M, Kleiner-Hancock H. Thymoquinone and cisplatin as a therapeutic combination in lung cancer: In vitro and in vivo. J Exp Clin Cancer Res 2010; 29:87; http://dx.doi.org/10.1186/1756-9966-29-87; PMID: 20594324
  • Banerjee S, Padhye S, Azmi A, Wang Z, Philip PA, Kucuk O, et al. Review on molecular and therapeutic potential of thymoquinone in cancer. Nutr Cancer 2010; 62:938 - 46; http://dx.doi.org/10.1080/01635581.2010.509832; PMID: 20924969
  • Burits M, Bucar F. Antioxidant activity of Nigella sativa essential oil. Phytother Res 2000; 14:323 - 8; http://dx.doi.org/10.1002/1099-1573(200008)14:5<323::AID-PTR621>3.0.CO;2-Q; PMID: 10925395
  • Abdel-Wahhab MA, Aly SE. Antioxidant property of Nigella sativa (black cumin) and Syzygium aromaticum (clove) in rats during aflatoxicosis. J Appl Toxicol 2005; 25:218 - 23; http://dx.doi.org/10.1002/jat.1057; PMID: 15856529
  • Collett GP, Campbell FC. Curcumin induces c-jun N-terminal kinase-dependent apoptosis in HCT116 human colon cancer cells. Carcinogenesis 2004; 25:2183 - 9; http://dx.doi.org/10.1093/carcin/bgh233; PMID: 15256484
  • Srivastava RK, Chen Q, Siddiqui I, Sarva K, Shankar S. Linkage of curcumin-induced cell cycle arrest and apoptosis by cyclin-dependent kinase inhibitor p21(/WAF1/CIP1). Cell Cycle 2007; 6:2953 - 61; http://dx.doi.org/10.4161/cc.6.23.4951; PMID: 18156803
  • Hsu JL, Chiang PC, Guh JH. Tunicamycin induces resistance to camptothecin and etoposide in human hepatocellular carcinoma cells: role of cell-cycle arrest and GRP78. Naunyn Schmiedebergs Arch Pharmacol 2009; 380:373 - 82; http://dx.doi.org/10.1007/s00210-009-0453-5; PMID: 19777212
  • Dhandapani KM, Mahesh VB, Brann DW. Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP-1 and NFkappaB transcription factors. J Neurochem 2007; 102:522 - 38; http://dx.doi.org/10.1111/j.1471-4159.2007.04633.x; PMID: 17596214
  • Ikeda R, Vermeulen LC, Lau E, Jiang Z, Pomplun M, Kolesar JM. Establishment and characterization of irinotecan-resistant human non-small cell lung cancer A549 cells. Mol Med Report 2010; 3:1031 - 4; PMID: 21472350
  • Lee CK, Ki SH, Choi JS. Effects of oral curcumin on the pharmacokinetics of intravenous and oral etoposide in rats: possible role of intestinal CYP3A and P-gp inhibition by curcumin. Biopharm Drug Dispos 2011; 32:245 - 51; http://dx.doi.org/10.1002/bdd.754; PMID: 21506134
  • Yu LL, Wu JG, Dai N, Yu HG, Si JM. Curcumin reverses chemoresistance of human gastric cancer cells by downregulating the NF-κB transcription factor. Oncol Rep 2011; 26:1197 - 203; PMID: 21811763
  • Qian H, Yang Y, Wang X. Curcumin enhanced adriamycin-induced human liver-derived Hepatoma G2 cell death through activation of mitochondria-mediated apoptosis and autophagy. Eur J Pharm Sci 2011; 43:125 - 31; http://dx.doi.org/10.1016/j.ejps.2011.04.002; PMID: 21514382
  • Martín-Cordero C, López-Lázaro M, Gálvez M, Ayuso MJ. Curcumin as a DNA topoisomerase II poison. J Enzyme Inhib Med Chem 2003; 18:505 - 9; http://dx.doi.org/10.1080/14756360310001613085; PMID: 15008515
  • Snyder RD, Arnone MR. Putative identification of functional interactions between DNA intercalating agents and topoisomerase II using the V79 in vitro micronucleus assay. Mutat Res 2002; 503:21 - 35; http://dx.doi.org/10.1016/S0027-5107(02)00028-3; PMID: 12052500
  • López-Lázaro M, Willmore E, Jobson A, Gilroy KL, Curtis H, Padget K, et al. Curcumin induces high levels of topoisomerase I- and II-DNA complexes in K562 leukemia cells. J Nat Prod 2007; 70:1884 - 8; http://dx.doi.org/10.1021/np070332i; PMID: 18076140
  • Harper JW, Elledge SJ. The DNA damage response: ten years after. Mol Cell 2007; 28:739 - 45; http://dx.doi.org/10.1016/j.molcel.2007.11.015; PMID: 18082599
  • Rouse J, Jackson SP. Interfaces between the detection, signaling, and repair of DNA damage. Science 2002; 297:547 - 51; http://dx.doi.org/10.1126/science.1074740; PMID: 12142523
  • Harrison JC, Haber JE. Surviving the breakup: the DNA damage checkpoint. Annu Rev Genet 2006; 40:209 - 35; http://dx.doi.org/10.1146/annurev.genet.40.051206.105231; PMID: 16805667
  • Lu JJ, Cai YJ, Ding J. Curcumin induces DNA damage and caffeine-insensitive cell cycle arrest in colorectal carcinoma HCT116 cells. Mol Cell Biochem 2011; 354:247 - 52; http://dx.doi.org/10.1007/s11010-011-0824-3; PMID: 21526346
  • Roy M, Sinha D, Mukherjee S, Biswas J. Curcumin prevents DNA damage and enhances the repair potential in a chronically arsenic-exposed human population in West Bengal, India. Eur J Cancer Prev 2011; 20:123 - 31; http://dx.doi.org/10.1097/CEJ.0b013e328341017a; PMID: 21332098
  • Saleh EM, El-Awady RA, Abdel Alim MA, Abdel Wahab AH. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells. Cell Biochem Biophys 2009; 55:95 - 105; http://dx.doi.org/10.1007/s12013-009-9058-3; PMID: 19593673
  • Jackson SP, Bartek J. The DNA-damage response in human biology and disease. Nature 2009; 461:1071 - 8; http://dx.doi.org/10.1038/nature08467; PMID: 19847258
  • Kepp O, Tesniere A, Schlemmer F, Michaud M, Senovilla L, Zitvogel L, et al. Immunogenic cell death modalities and their impact on cancer treatment. Apoptosis 2009; 14:364 - 75; http://dx.doi.org/10.1007/s10495-008-0303-9; PMID: 19145485
  • Kroemer G, El-Deiry WS, Golstein P, Peter ME, Vaux D, Vandenabeele P, et al, Nomenclature Committee on Cell Death. Classification of cell death: recommendations of the Nomenclature Committee on Cell Death. Cell Death Differ 2005; 12:Suppl 2 1463 - 7; http://dx.doi.org/10.1038/sj.cdd.4401724; PMID: 16247491
  • Galluzzi L, Maiuri MC, Vitale I, Zischka H, Castedo M, Zitvogel L, et al. Cell death modalities: classification and pathophysiological implications. Cell Death Differ 2007; 14:1237 - 43; http://dx.doi.org/10.1038/sj.cdd.4402148; PMID: 17431418
  • Aoki H, Takada Y, Kondo S, Sawaya R, Aggarwal BB, Kondo Y. Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways. Mol Pharmacol 2007; 72:29 - 39; http://dx.doi.org/10.1124/mol.106.033167; PMID: 17395690
  • Saiki S, Sasazawa Y, Imamichi Y, Kawajiri S, Fujimaki T, Tanida I, et al. Caffeine induces apoptosis by enhancement of autophagy via PI3K/Akt/mTOR/p70S6K inhibition. Autophagy 2011; 7:176 - 87; http://dx.doi.org/10.4161/auto.7.2.14074; PMID: 21081844
  • Ohno Y, Yagi H, Nakamura M, Masuko K, Hashimoto Y, Masuko T. Simultaneous induction of apoptotic, autophagic, and necrosis-like cell death by monoclonal antibodies recognizing chicken transferrin receptor. Biochem Biophys Res Commun 2008; 367:775 - 81; http://dx.doi.org/10.1016/j.bbrc.2008.01.030; PMID: 18201558

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.